You just read:

RegeneRx Joint Venture Partner Receives $7.28 million USD From Korean Government and Venture Fund for U.S. Development of RGN-259/GBT-201

News provided by

RegeneRx Biopharmaceuticals, Inc.

Mar 09, 2015, 08:30 ET